More articles from Cardiology

You have access
Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
Richard Sekerak, MD, Johanna Ben-Ami Lerner, MD, Pooja Prasad, MD and Megha Prasad, MD

Cleveland Clinic Journal of Medicine October 2023, 90 (10) 607-609; DOI: https://doi.org/10.3949/ccjm.90a.23004

These conditions often co-exist and can have complex interactions. The progression of kidney disease increases the risk of major adverse cardiovascular events.
You have access
What is the most appropriate management of patients with acute decompensated heart failure who develop in-hospital hypotension?
Lorenzo Braghieri, MD, Warren A. Skoza, MD, Osamah Z. Badwan, MD and Paulino Alvarez, MD

Cleveland Clinic Journal of Medicine October 2023, 90 (10) 625-631; DOI: https://doi.org/10.3949/ccjm.90a.22095

The authors offer a tailored approach to risk-stratification in these patients that focuses on early recognition and management of symptomatic and clinically significant hypotension.